Advertisement

Topics

Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice

20:00 EDT 3 Jul 2017 | BioMed Central

Fibroblast growth factor 21 (FGF21) is an endocrine-acting hormone that has the potential to treat diabetic nephropathy. However, development of FGF21 into a therapeutic has been hindered due to its low intrin...

Original Article: Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice

NEXT ARTICLE

More From BioPortfolio on "Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...